In Treatment of Bacterial infections Oflab 200 Tablet is a medicine that is used to treat various bacterial infections such as pneumonia, bronchitis and infections of the bladder, urinary tract. It also contains beneficial bacteria that protect the inner layers of your stomach and intestines. This medicine can relieve frequent loose motions and also help you to stay well by preventing them from coming back. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
It is unsafe to consume alcohol with Oflab 200 Tablet.
Oflab 200 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Oflab 200 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Oflab 200 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Oflab 200 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Oflab 200 Tablet may be needed. Please consult your doctor.
Oflab 200 Tablet should be used with caution in patients with liver disease. Dose adjustment of Oflab 200 Tablet may be needed. Please consult your doctor.
If you miss a dose of Oflab 200 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Alpha Aromatic Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Syntro Health Care || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Litaka Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ozone Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ronyd Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)